Graf WD - Search Results

1

Radical reactions from missing ceruloplasmin: the importance of a ferroxidase as an endogenous antioxidant.

Graf WD, Noetzel MJ. Graf WD, et al. Neurology. 1999 Aug 11;53(3):446-7. doi: 10.1212/wnl.53.3.446. Neurology. 1999. PMID: 10449102 No abstract available.

2

Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation").

Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, Sumi M, DiMauro S. Silvestri G, et al. Among authors: graf wd. Neurology. 1993 Jun;43(6):1200-6. doi: 10.1212/wnl.43.6.1200. Neurology. 1993. PMID: 8170567

3

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.

Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, Womble G, Risner M, Manasco P. Duchowny M, et al. Among authors: graf wd. Neurology. 1999 Nov 10;53(8):1724-31. doi: 10.1212/wnl.53.8.1724. Neurology. 1999. PMID: 10563619 Clinical Trial.

4

Can bioinformatics help trace the steps from gene mutation to disease?

Graf WD. Graf WD. Neurology. 2000 Aug 8;55(3):331-3. doi: 10.1212/wnl.55.3.331. Neurology. 2000. PMID: 10932261 Review. No abstract available.

5

Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.

Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ. Furukawa Y, et al. Among authors: graf wd. Neurology. 2001 Jan 23;56(2):260-3. doi: 10.1212/wnl.56.2.260. Neurology. 2001. PMID: 11160968

6

Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA.

Graf WD, Sumi SM, Copass MK, Ojemann LM, Longstreth WT Jr, Shanske S, Lombes A, DiMauro S. Graf WD, et al. Ann Neurol. 1993 Jun;33(6):640-5. doi: 10.1002/ana.410330613. Ann Neurol. 1993. PMID: 8388680

7

Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation.

Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, Barshop BA, Courchesne E, Haas RH. Graf WD, et al. J Child Neurol. 2000 Jun;15(6):357-61. doi: 10.1177/088307380001500601. J Child Neurol. 2000. PMID: 10868777

8

Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.

Hamer HM, Dodel R, Strzelczyk A, Balzer-Geldsetzer M, Reese JP, Schöffski O, Graf W, Schwab S, Knake S, Oertel WH, Rosenow F, Kostev K. Hamer HM, et al. J Neurol. 2012 Nov;259(11):2376-84. doi: 10.1007/s00415-012-6509-3. Epub 2012 Apr 28. J Neurol. 2012. PMID: 22544296

9

Nonadherence to antiepileptic drugs in Germany: A retrospective, population-based study.

Gollwitzer S, Kostev K, Hagge M, Lang J, Graf W, Hamer HM. Gollwitzer S, et al. Neurology. 2016 Aug 2;87(5):466-72. doi: 10.1212/WNL.0000000000002791. Epub 2016 Jul 1. Neurology. 2016. PMID: 27371490

10

Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: A nationwide study of prescription data in Germany.

Lang JD, Kostev K, Onugoren MD, Gollwitzer S, Graf W, Müller T, Olmes DG, Hamer HM. Lang JD, et al. Ann Neurol. 2018 Dec;84(6):918-925. doi: 10.1002/ana.25353. Epub 2018 Nov 8. Ann Neurol. 2018. PMID: 30298621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters